CNTNAP2 and autoimmune encephalitis: Given that mRS 0–2 is typically classified as a “good” outcome, yet shows huge variability in EQ5DVAS, our observation calls for QoL measures to replace mRS in future studies of CASPR2 antibody disease, and likely other forms of autoimmune encephalitis.16, 17